Preterm Birth and PROM Testing Market Growing Due to Prenatal Screening Advancements and NICU Preparedness

The preterm birth and PROM testing industry is witnessing significant transformation driven by advancements in diagnostic technologies and increasing awareness about prenatal care. Over the past few years, enhanced focus on maternal and fetal health across both developed and emerging economies has catalyzed the demand for precise and early detection methods. Innovations in biomarker identification and point-of-care testing solutions are further elevating the market potential. The Global Preterm Birth and PROM Testing Market size is estimated to be valued at USD 1.92 billion in 2025 and is expected to reach USD 2.94 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. This robust market growth is underpinned by increasing preterm birth rates worldwide and the consequent demand for reliable diagnostic screening protocols.

Click here to Get Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/6403

➤Analyst Opinion

● Increasing adoption of biomarker-based testing technologies is a critical supply-side indicator driving market growth. In 2024, the global production capacity for rapid PROM diagnostic kits increased by around 18%, reflecting manufacturers' response to rising clinical demand.

● Demand-side analysis reveals that expanding prenatal monitoring programs, particularly in North America and Asia Pacific, have led to a 15% surge in test utilization rates among high-risk pregnancies in 2025, contributing substantially to market revenue.

● Micro-segmentation studies emphasize the growing preference for non-invasive PROM testing methods in outpatient settings, with clinical trials reporting improved sensitivity rates above 90%, highlighting a shift in testing protocols.

● Consolidation trends among diagnostic firms have influenced the competitive landscape, where strategic partnerships focused on multiplex assay development helped increase market share by nearly 7% for key market players in 2024.

➤Market Taxonomy and Regional coverage of Report

● By Test Type: Biomarker Testing, Immunoassay, Molecular Diagnostics, Point-of-Care Testing, Others
● By Application: Preterm Labor Detection, PROM Diagnosis, Risk Assessment, Monitoring & Follow-up, Others
● By End User: Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Homecare Settings, Others

Regional and Country Analysis:
● North America: U.S. and Canada
● Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
● Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
● Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
● Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

Buy the Complete Report with an Impressive Discount (Up to 25% Off) at: https://www.coherentmarketinsights.com/insight/buy-now/6403

➤Leading Companies of the Market

● Abbott Laboratories
● Biosynex
● Qiagen N.V.
● Clinical Innovations, LLC
● Sera Prognostics
● Hologic, Inc.
● IQ Products
● NX Prenatal, Inc.
● Promega Corporation
● Insight Pharmaceuticals LLC
● Creative Diagnostics

● Industry leaders are leveraging innovation-driven growth strategies; for instance, Abbott Laboratories expanded its molecular diagnostics portfolio through acquisition deals enhancing its preterm birth testing capabilities, resulting in a 12% increase in market share in 2024.
● Sera Prognostics invested heavily in predictive analytics and biomarker discovery, leading to successful clinical validation of tests with improved accuracy, thus expanding its footprint in North America and Asia Pacific markets.

➤Key Growth Drivers Fuelling Market Expansion

Several factors are propelling the Preterm Birth and PROM Testing Market growth. Increasing incidents of preterm births propelled by maternal complications and infection rates have intensified the demand for early diagnostic interventions. According to WHO, approximately 15 million babies are born preterm annually worldwide, underscoring the market revenue opportunity. Technological advancements such as the integration of AI with diagnostic platforms are optimizing test accuracy and reducing turnaround times, enhancing clinical adoption. Government initiatives promoting maternal health and reimbursement policies for prenatal diagnostics in regions like North America and Europe are creating favorable market conditions. Moreover, awareness campaigns and improved prenatal care accessibility in emerging economies are expanding the market scope, particularly in Asia Pacific, which witnessed a 20% growth in preterm birth diagnostic test adoption in 2025.

➤Key Reasons for Buying the Preterm Birth And PROM Testing Market Report

✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the Preterm Birth and PROM Testing Market
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the Preterm Birth and PROM Testing Market
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the Preterm Birth and PROM Testing Market

📌 Get Instant Access! Purchase Research Report and Receive a 25% Discount with limited-time offer@ https://www.coherentmarketinsights.com/insight/buy-now/6403

➤ Emerging Trends and Market Shift

The market is witnessing a decisive shift toward precision medicine with the emergence of multi-marker assay panels that facilitate better risk stratification for preterm labor. Moreover, decentralized testing in homecare settings is gaining traction, allowing early intervention with increased convenience and lower healthcare costs. Smart wearable devices integrated with PROM testing functionalities are expected to reshape prenatal monitoring strategies by 2026. Additionally, there is a clear trend toward combination diagnostics that leverage molecular and immunological biomarkers for improved clinical outcomes. Regions like Europe are leading in adoption due to robust regulatory frameworks encouraging innovation. As per recent clinical data, diagnostic accuracy has improved by roughly 8% in 2024 owing to these technological advancements, fostering further market growth.

➤High-Impact Market Opportunities by Segment and Region

Significant opportunities exist in the Biomarker Testing segment as ongoing clinical research focuses on novel proteomic and genomic biomarkers capable of predicting PROM and preterm birth more reliably, potentially driving segment growth beyond the current CAGR. The Point-of-Care Testing segment benefits from escalating demand for rapid diagnostics in low-resource settings, where turnaround time is critical, presenting a lucrative market expansion avenue. Hospitals & Clinics remain the largest end user, with increasing investments in advanced prenatal care facilities enabling wider adoption of PROM testing solutions. Regionally, Asia Pacific offers compelling opportunities backed by rising healthcare infrastructure investments and increasing collaborations between local governments and private enterprises aimed at improving maternal healthcare accessibility. This region showed a 22% revenue growth in 2025 within the preterm birth diagnostic space.

❓ Frequently Asked Questions

1. Who are the dominant players in the Preterm Birth and PROM Testing Market?
Leading companies include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, and Hologic, Inc., who together drive technological innovation and hold substantial market share.

2. What will be the size of the Preterm Birth and PROM Testing Market in the coming years?
The market size is forecasted to reach USD 2.94 billion by 2032, growing at a CAGR of 6.3% from 2025 onwards, reflecting consistent expansion driven by rising clinical demand and technological advancements.

3. Which end users industry has the largest growth opportunity?
Hospitals and clinics represent the largest segment due to increased investments in maternal care and prenatal diagnostics infrastructure, creating significant business growth opportunities in this sector.

4. How will market development trends evolve over the next five years?
The market trends point toward adoption of multiplex biomarker assays, point-of-care testing enhancements, and digital integration of prenatal diagnostics, facilitating improved diagnostic accuracy and faster market adoption globally.

5. What is the nature of the competitive landscape and challenges in the Preterm Birth and PROM Testing Market?
The competitive landscape is characterized by rapid technological innovation and consolidation activities. Market challenges include the need for regulatory approvals and high development costs, offset by strategic partnerships and increased R&D spending.

6. What go-to-market strategies are commonly adopted in the Preterm Birth and PROM Testing Market?
Market players commonly employ mergers & acquisitions, product portfolio diversification, and collaborations with healthcare institutions to enhance their market presence and share across regions.

This comprehensive preterm birth and PROM testing market report integrates current market insights, industry size, market share dynamics, and emerging trends, ensuring actionable knowledge for stakeholders and experts seeking to capitalize on promising growth strategies and high-impact market opportunities.

✍️ PR Authored By:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.

About Us:

With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

☎️ Contact Us:

533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-8-7924-7805
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

This release was published on openPR.